EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Prognostic Effect of Preoperative Albumin-to-Globulin Ratio in Patients with Non-Metastatic Bladder Cancer Undergoing Radical Cystectomy

Haruko Takada, Masaomi Ikeda, Rena Tanaka, Noriaki Samejima, Takahiro Harano, Shinya Kobayashi, Masayoshi Toyoda, Mizuho Kawamura, Satoshi Okuda, Risa Hada, Izuru Shiba, Yutaka Shiono, Soichiro Shimura, Kohei Mori, Shuhei Hirano, Dai Koguchi, Hideyasu Tsumura, Daisuke Ishii, Kazumasa Matsumoto

Oncology · 2026-02-06 · 104 (8) · 880-890

DOI: 10.1159/000550892 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Blood-based inflammatory and nutritional biomarkers have been crucial prognostic indicators in various malignancies. This study aimed to investigate the association of preoperative biomarkers with postoperative outcome in patients with non-metastatic bladder cancer (clinical stage ≤IIIb) who underwent radical cystectomy (RC). Methods: This study retrospectively analyzed data, including preoperative albumin-to-globulin ratio (AGR), neutrophil-to-lymphocyte ratio (NLR), and C-reactive protein-to-albumin ratio (CAR), of 235 patients with non-metastatic bladder cancer who underwent RC at 10 Kitasato University-affiliated hospitals between 2002 and 2023. Results: Survival analyses revealed the significant association of low AGR with poorer 5-year disease-free survival (DFS) (31% vs. 64%, p < 0.001) and overall survival (OS) (44% vs. 70%, p < 0.001). High NLR correlated with DFS (53% vs. 72%, p = 0.008) and OS (59% vs. 79%, p = 0.009), whereas high CAR was significant only for OS (39% vs. 60%, p = 0.001). Multivariable analysis demonstrated that low AGR was significantly associated with poorer DFS (hazard ratio [HR]: 1.75; 95% confidence interval [CI]: 1.02–2.98; p = 0.041) and OS (HR: 1.83; 95% CI: 1.04–3.22; p = 0.037). Conclusion: Preoperative blood-based biomarkers may help identify patients at high risk of non-metastatic bladder cancer after RC. In particular, AGR provides a simple, inexpensive, and widely applicable tool for risk stratification and treatment planning.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →